The Global Bone Cement Market Size was valued at US$ 657.8 Million in 2024 and is projected to expand at a 5.2% CAGR through 2035. Increasing cases of osteoporosis, joint replacements, and trauma ...

The Global Bone Cement Industry is set to expand steadily, driven by rising musculoskeletal disorders, technological advancements in orthopedic surgery, and innovative product developments. The bone ...

It was utilized in the treatment of chronic osteomyelitis caused by MRSA infection, with gentamicin sulfate-loaded PMMA bone cement and intravenous vancomycin drip serving as control groups. Over time ...

In recent years, some scholars have applied antibiotic-containing gentamicin bone cement to treat various wounds with some success. However, there are no reports of repair of tendon-exposed wounds ...

But the rise of drug-resistant bacteria calls for new approaches to these types of problems, and a potent new form of bone cement is poised to take up the fight. “Currently, the Food and Drug ...

Now, researchers from Brigham and Women’s Hospital have developed a specialized drug-device delivery system to identify an effective antibiotic for targeted use in a bone cement matrix.

To engineer a new antibiotic for specific local delivery via a bone cement matrix, polymethylmethacrylate (PMMA) bone cement was used — the accepted FDA gold-standard. The team shortlisted ...

To engineer a new antibiotic for specific local delivery via a bone cement matrix, polymethylmethacrylate (PMMA) bone cement was used -- the accepted FDA gold-standard. The team shortlisted ...

Credit: Shutterstock. Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler. The Food and Drug Administration (FDA) has cleared Cerament G for use as a bone void filler in ...